Transarterielle Chemoembolisation von Lebermetastasen: Indikationsstellung, Technik, Ergebnisse

We have analyzed the effectiveness of repetitive transarterial chemoembolization (TACE) of liver metastases as a neoadjuvant or palliative treatment modality in comparison with published data. Chemoembolization of liver metastases is performed with different cytotoxic drugs. In a 4-week interval, 357 patients were treated with repetitive 1,158 TACE courses performed with lipiodol, mitomycin C and spherex. 254 patients were treated palliatively, 18 patients symptomatically and 79 patients via the neoadjuvant protocol, 71 patients of whom received additional MR-guided laser-induced thermoablation (LITT) of the metastases after TACE. Our results were compared with the literature. Most of the patients with a low rate of local complications like vascular occlusion or liver abscess could be treated successfully using TACE. In 81 % of the treated lesions a primary high lipiodol retention was observed. In the palliative group a reduction of the tumor size was noted in 36 % of the lesions, a growth stop in 24 % and a reduction of the tumor growth rate in 40 %. In 70 % of the patients treated neodadjuvantly a reduction of the tumor size was found. The median survival rate of our collective of patients with liver metastases averages 8.6 months. In the literature median survival rates in patients with liver metastases were between 8.5 and 23 months after TACE. TACE is judged as a minimal invasive and outpatient treatment protocol for liver metastases. A combination of TACE and different local treatment modalities presents a neoadjuvant treatment strategy to control the diseased liver.

[1]  T. Vogl1,et al.  CT-gesteuerte perkutane intratumorale Chemotherapie mit Cisplatin-/Adrenalin-Gel zur Behandlung inoperabler maligner Lebertumoren , 2000 .

[2]  L. Saltz,et al.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.

[3]  Steven A. Curley,et al.  Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis , 2000, Annals of surgery.

[4]  P. Ruszniewski,et al.  Hepatic Arterial Chemoembolization in the Management of Advanced Digestive Endocrine Tumors , 2000, Digestion.

[5]  P R Mueller,et al.  Treatment of intrahepatic malignancy with radiofrequency ablation , 2000, Cancer.

[6]  I. Finlay,et al.  Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  M. Mack,et al.  Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. , 2000, Radiology.

[8]  V. Vilgrain,et al.  Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours , 2000, European journal of gastroenterology & hepatology.

[9]  M. Mack,et al.  Interventionelle MR-gesteuerte laserinduzierte Thermotherapie bei onkologischen Fragestellungen Stand und Ausblick , 1999, Der Radiologe.

[10]  J. Doroshow,et al.  Hepatic chemoembolization combined with systemic infusion of 5‐fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma , 1999, Cancer.

[11]  C. Bassi,et al.  Role of Chemoembolization in Synchronous Liver Metastases from Pancreatic Endocrine Tumours , 1999, Digestive Surgery.

[12]  A. Benson,et al.  Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature , 1998, Cancer.

[13]  W. B. Ross,et al.  Hepatic resection with cryotherapy to involved or inadequate resection margin (edge freeze) for metastases from colorectal cancer , 1998, The British journal of surgery.

[14]  R. Felix,et al.  Dopplersonographische Verlaufskontrolle der Perfusion hepatozellulärer Karzinome nach arterieller Chemoembolisation , 1998 .

[15]  J. Lois,et al.  Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies. , 1997, The American surgeon.

[16]  L. Ellis,et al.  Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine , 1995, Cancer.

[17]  E. Schiff,et al.  A Phase I Study of Chemoembolization with Cisplatin and Lipiodol for Primary and Metastatic Liver Cancer , 1994, American journal of clinical oncology.

[18]  C. Claussen,et al.  Chemoembolisation des hepatozellulären Karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiv repetitiver Therapie , 1994 .

[19]  C. Brown,et al.  Colorectal metastases to the liver: selective chemoembolization. , 1993, Radiology.

[20]  T. de Baère,et al.  Transcatheter chemoembolization of progressive carcinoid liver metastasis. , 1993, Radiology.

[21]  M. Kameyama,et al.  Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer. , 1993, Surgery.

[22]  M. Clouse,et al.  Hepatic arterial chemoembolization for metastatic endocrine tumors. , 1993, Journal of vascular and interventional radiology : JVIR.

[23]  M. Pentecost,et al.  Hepatic chemoembolization: safety with portal vein thrombosis. , 1993, Journal of vascular and interventional radiology : JVIR.

[24]  E. Unger,et al.  CT Findings After Hepatic Chemoembolization , 1992, Journal of computer assisted tomography.

[25]  W. Lauchart,et al.  Chemoembolisation primärer Leberkarzinome mit Epirubicin-Lipiodol , 1991 .

[26]  H. Dralle,et al.  Die Chemoembolisation von Karzinoidmetastasen in der Leber , 1990 .

[27]  S. Fukushima,et al.  Intraarterial infusion of 5‐fluoro‐2‐deoxyuridine‐C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report , 1989, Cancer.

[28]  H. Taniguchi,et al.  Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anti‐cancer agents suspended in a lipid contrast medium , 1989, Cancer.

[29]  S. Shinohara,et al.  Treatment of Liver Metastases by Arterial Injection of Adriamycin/Mitomycin C Lipiodol Suspension , 1989, Acta radiologica.

[30]  C. Charnsangavej,et al.  Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. , 1988, JAMA.

[31]  M. Sternlicht,et al.  Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney. , 1988, Cancer research.

[32]  S. Shinohara,et al.  Intra-Arterial Injection of Adriamycin/Mitomycin C Lipiodol Suspension in Liver Metastases , 1987, Acta radiologica.

[33]  G. Thieme,et al.  Die intraarterielle digitale Subtraktionsangiographie (i.a. DSA) in der präoperativen Diagnostik raumfordernder Prozesse des Abdomens , 1986 .

[34]  N. Bachur,et al.  Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. , 1984, The Journal of biological chemistry.

[35]  S. Wallace,et al.  Interventional approaches to hepatic tumor treatment. , 1983, Seminars in roentgenology.

[36]  S. Wallace,et al.  The radiologic diagnosis and management of hepatic metastases. , 1982, Der Radiologe.

[37]  S. Wallace,et al.  THE PALLIATIVE ROLE OF HEPATIC ARTERIAL INFUSION AND ARTERIAL OCCLUSION IN COLORECTAL CARCINOMA METASTATIC TO THE LIVER , 1981, The Lancet.

[38]  S. Rockwell,et al.  Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. , 1980, Cancer research.

[39]  T. Vogl,et al.  Kontrastmittelverstärkte Magnetresonanztomographie von Lebermetastasen: Positive versus negative Kontrastmittel , 2001, Der Radiologe.

[40]  J. Douillard.  Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer. , 2000, Oncology.

[41]  P. Neuhaus,et al.  Multisequentielle arterielle Chemoembolisation fortgeschrittener hepatozellulärer Karzinome: Computertomographische Verlaufsparameter zur Beurteilung des Ansprechens auf die Therapie , 2000 .

[42]  K. Engelmann,et al.  Liver metastases: interventional therapeutic techniques and results, state of the art , 1999, European Radiology.

[43]  J. Ajani,et al.  Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. , 1998, AJR. American journal of roentgenology.

[44]  K. Runge.  Stand und Ausblick , 1998 .

[45]  C. Bartolozzi,et al.  Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate , 1998, European Radiology.

[46]  J. Gross,et al.  Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. , 1980, Cancer treatment reports.